Open Access

Clinical scenario 2: Identifying patients eligible for extended VTE treatment: Insights from EINSTEIN CHOICE and EINSTEIN EXT.

Presentation

About the speaker

Doctor Jeffrey Weitz

Thrombosis & Atherosclerosis Research Institute (TaARI), Hamilton (Canada)
20 presentations
0 follower

6 more presentations in this session

Welcome and introduction.

Speaker: Professor S. Konstantinides (Mainz, DE)

Thumbnail

Clinical scenario 1: Anticoagulation for patients with pulmonary embolism from hospital to home: Insights from the 2019 ESC PE guideline updates and HOT-PE trial.

Speaker: Professor S. Konstantinides (Mainz, DE)

Thumbnail

Clinical scenario 3: Interpreting the evidence base for rivaroxaban in the treatment of cancer-associated thrombosis: What does it mean for your patient?

Speaker: Professor A. Khorana (Cleveland, US)

Thumbnail

Access the full session

Treatment challenges in VTE: Exploring solutions with rivaroxaban across three clinical scenarios

Speakers: Doctor J. Weitz, Professor S. Konstantinides, Professor S. Konstantinides, Professor A. Khorana
Thumbnail

About the event

Image

ESC CONGRESS 2020 - The Digital Experience

28 August - 1 September 2020

Sessions Presentations

Related content

Open Access

Introduction: Digital health and CVD prevention - natural partners.

28 August 2021

ESC Premium Access

Severe biventricular myocardial involvement in Systemic sclerosis.

27 August 2021

ESC Premium Access

Edoxaban treatment in real-world practice is highly concordant with ESC atrial fibrillation guidelines: results from the non-interventional global ETNA-AF program

27 August 2021

This platform is supported by

logo Novo Nordisk